| pubmed-article:1313399 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1313399 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:1313399 | lifeskim:mentions | umls-concept:C0025500 | lld:lifeskim |
| pubmed-article:1313399 | lifeskim:mentions | umls-concept:C1554877 | lld:lifeskim |
| pubmed-article:1313399 | lifeskim:mentions | umls-concept:C0055667 | lld:lifeskim |
| pubmed-article:1313399 | lifeskim:mentions | umls-concept:C0650883 | lld:lifeskim |
| pubmed-article:1313399 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:1313399 | pubmed:dateCreated | 1992-5-5 | lld:pubmed |
| pubmed-article:1313399 | pubmed:abstractText | Pathological effects of asbestos are probably dependent on the size and surface properties of the fibers. Surface-modified chrysotile fibers were injected into the pleural cavity of rats to investigate the potency of the fiber to induce mesothelioma. Chrysotile fibers were modified by a phosphorylation process, resulting in the presence of phosphorus at the fiber surface. Phosphorylated samples were characterized by enhanced durability and reduced affinity for biological macromolecules. Five samples were tested: 1 untreated and 4 phosphorylated. ChrP1, ChrP2 and ChrP3 corresponded to phosphorylated samples obtained by first, second and third passages through an Alpine classifier; Pm was defibrillated ChrP1. The number of fibers per microgram and the size distribution were determined by transmission electron microscopy and classified in 4 size groups. Groups of 35 rats were inoculated with 20 mg of fibers suspended in 0.9% NaCl solution. No mesothelioma was found in the saline controls. All fiber samples were proficient in producing mesothelioma; the percentages were different between groups and untreated chrysotile but not significantly so. The differences may be explained on the basis of the number of fibers injected which were greater than 8 microns in length and less than 0.25 microns in diameter. The findings of a proficiency of long fibers to produce mesothelioma, previously reported by others for glass fibers, could be applied to chrysotile. | lld:pubmed |
| pubmed-article:1313399 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1313399 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1313399 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1313399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1313399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1313399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1313399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1313399 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1313399 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:1313399 | pubmed:issn | 0020-7136 | lld:pubmed |
| pubmed-article:1313399 | pubmed:author | pubmed-author:FleuryJJ | lld:pubmed |
| pubmed-article:1313399 | pubmed:author | pubmed-author:JaurandM CMC | lld:pubmed |
| pubmed-article:1313399 | pubmed:author | pubmed-author:MonchauxGG | lld:pubmed |
| pubmed-article:1313399 | pubmed:author | pubmed-author:NebutMM | lld:pubmed |
| pubmed-article:1313399 | pubmed:author | pubmed-author:JansonXX | lld:pubmed |
| pubmed-article:1313399 | pubmed:author | pubmed-author:Van der... | lld:pubmed |
| pubmed-article:1313399 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1313399 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:1313399 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:1313399 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1313399 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1313399 | pubmed:pagination | 937-42 | lld:pubmed |
| pubmed-article:1313399 | pubmed:dateRevised | 2007-7-24 | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:meshHeading | pubmed-meshheading:1313399-... | lld:pubmed |
| pubmed-article:1313399 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1313399 | pubmed:articleTitle | Mesothelioma in rats following intrapleural injection of chrysotile and phosphorylated chrysotile (chrysophosphate). | lld:pubmed |
| pubmed-article:1313399 | pubmed:affiliation | INSERM U139, Hôpital Henri Mondor, Créteil, France. | lld:pubmed |
| pubmed-article:1313399 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1313399 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1313399 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1313399 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1313399 | lld:pubmed |
